Compare TECX & BRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TECX | BRSP |
|---|---|---|
| Founded | 2019 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Real Estate Investment Trusts |
| Sector | | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 618.9M | 632.6M |
| IPO Year | 2018 | 2017 |
| Metric | TECX | BRSP |
|---|---|---|
| Price | $30.57 | $4.69 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $75.20 | $6.50 |
| AVG Volume (30 Days) | 209.7K | ★ 1.1M |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 11.03% |
| EPS Growth | 40.70 | ★ 75.24 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $330,587,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $17.54 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $14.39 | $4.69 |
| 52 Week High | $39.53 | $6.17 |
| Indicator | TECX | BRSP |
|---|---|---|
| Relative Strength Index (RSI) | 39.19 | 30.01 |
| Support Level | $27.30 | N/A |
| Resistance Level | $31.39 | $5.75 |
| Average True Range (ATR) | 2.46 | 0.08 |
| MACD | -0.67 | -0.01 |
| Stochastic Oscillator | 3.84 | 2.41 |
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
BrightSpire Capital Inc is an internally-managed commercial real estate credit REIT focused on originating, acquiring, financing and managing a diversified portfolio of commercial real estate debt and net lease real estate investments predominantly in the United States. CRE debt investments consist of first mortgage loans with the objective of generating consistent risk-adjusted returns. The operating segments of the company are Senior and Mezzanine Loans and Preferred Equity, Net Leased and Other Real Estate, Corporate and Other. Geographically, the company generates revenue from the United States.